Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study - Ross, David M.; Saußele, Susanne (Journal of cancer research and clinical oncology, 2018)
Gesehen am 29.09.2020